Annotation Detail

Information
Associated Genes
MLH1
Associated Variants
MLH1 p.Thr117Met (p.T117M) ( ENST00000455445.6, ENST00000485889.2, ENST00000492474.6, ENST00000539477.6, ENST00000536378.5, ENST00000231790.8, ENST00000435176.5, ENST00000466900.6, ENST00000441265.6, ENST00000456676.7, ENST00000458205.6, ENST00000450420.6, ENST00000616768.6, ENST00000673673.2, ENST00000673715.1, ENST00000673899.1, ENST00000673990.2, ENST00000674019.1, ENST00000713802.1 )
MLH1 p.Thr117Met (p.T117M) ( ENST00000231790.8, ENST00000435176.5, ENST00000441265.6, ENST00000450420.6, ENST00000455445.6, ENST00000456676.7, ENST00000458205.6, ENST00000466900.6, ENST00000485889.2, ENST00000492474.6, ENST00000536378.5, ENST00000539477.6, ENST00000616768.6, ENST00000673673.2, ENST00000673715.1, ENST00000673899.1, ENST00000673990.2, ENST00000674019.1, ENST00000713802.1 )
Associated Disease
Lynch syndrome
Source Database
CIViC Evidence
Description
This variant, identified in three cases of microsatellite-unstable colorectal cancer was confirmed to be somatic in patients with suspected Lynch Syndrome (LS). The patients were therefore negative for LS. However, based on this study we can infer that the variant would predispose to LS in a germline setting. Two patients had loss of heterozygosity effecting the wildtype allele while one patient harbored a second MLH1 mutation (p.I68S).
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/1806
Gene URL
https://civic.genome.wustl.edu/links/genes/3532
Variant URL
https://civic.genome.wustl.edu/links/variants/743
Rating
2
Evidence Type
Predisposing
Disease
Lynch Syndrome
Evidence Direction
Supports
Evidence Level
E
Clinical Significance
Uncertain Significance
Pubmed
25111426
Drugs